te Dr Reddy's Laboratories: Today Latest News, Photos, Videos about Dr Reddy's Laboratories - Zee Business

हिंदी में पढ़ें

Dr Reddy's Laboratories

Dr Reddy's Labs Hyderabad facility gets 9 observations from US drug regulator; shares fall

Dr Reddy's Labs Hyderabad facility gets 9 observations from US drug regulator; shares fall

Fri, Oct 13, 2023

At around 12:42 p.m., shares of Dr Reddy's Laboratories traded 0.85 per cent or Rs 46.8 lower at Rs 5,483.1 apiece. The stock fell for the second straight day and the market capitalisation of the company stood at Rs 91,737.16 crore.

Dr Reddy's Q4 2023 preview: Here is what to expect from the drug maker

Dr Reddy's Q4 2023 preview: Here is what to expect from the drug maker

Tue, May 09, 2023

Dr Reddy Q4 results 2023 preview: The pharmaceutical company is likely to report a 13 per cent year-on-year (YoY) increase in its consolidated revenue to Rs 6,174 crore against Rs 5,475 crore logged in Q4FY2023, according to Zee Business Research.

Top Gainers & Losers: Dr Reddy’s Labs, Bajaj Auto end in green, Power Grid dips nearly 2%

Top Gainers & Losers: Dr Reddy’s Labs, Bajaj Auto end in green, Power Grid dips nearly 2%

Wed, Apr 12, 2023

Top Gainers & Losers: TCS will kick start the Q4 earnings season later in the day. Industrial Production data for February and March inflation rates are scheduled to be announced post-market hours.

TRENDING NOW

Pharma stocks a mixed bag as drug regulator NPPA fixes retail price of 74 drug formulations

Pharma stocks a mixed bag as drug regulator NPPA fixes retail price of 74 drug formulations

Tue, Feb 28, 2023

The National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the prices under the Drugs (Price Control) Order 2013 based on the decision of the 109th authority meeting held on February 21 this year, according to a PTI report.

Wipro, Bajaj Auto, Dr Reddy's among stocks in focus today | Check What Brokerage firm Recommends

Wipro, Bajaj Auto, Dr Reddy's among stocks in focus today | Check What Brokerage firm Recommends

Tue, Feb 28, 2023

Brokerages are bullish on Dr Reddy's Laboratories, Bajaj Auto, and skeptical on Wipro. Here's what top brokerages recommend on some of the key stocks in focus today.

Dr Reddy's to buy US generic product portfolio of Australia-based Mayne Pharma

Dr Reddy's to buy US generic product portfolio of Australia-based Mayne Pharma

Mon, Feb 27, 2023

The acquisition will complement Dr Reddy's US retail prescription pharmaceutical business with limited competition products.

Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today

Tata Motors, Bajaj Auto, Dr Reddy’s Laboratories, and Cipla are in focus ahead of Q3 results today

Wed, Jan 25, 2023

Shares of Tata Motors and Bajaj Auto were trading flat with a positive bias at Rs 422.40 and Rs 3,693 per share on the NSE in the early morning session on Wednesday.

Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug

Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug

Mon, Dec 19, 2022

The company further said it is initiating a global Phase III study to compare the efficacy, safety, tolerability and immunogenicity of 'DRL_TC' with the reference product in patients with moderate-to-severe active rheumatoid arthritis.

Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022

Dr Reddy’s out of Sensex pack; Tata Motors is new entrant - Check full list of 30 companies | Sensex Reshuffle December 2022

Mon, Dec 19, 2022

Dr Reddy’s Lab Share Price: Zee Business panellist and market expert Jay Thakkar said that Dr Reddy’s shares are trading in a range from Rs 4650 to Rs 3750. He, however, said that the range is contracting gradually and trading between Rs 4250 and Rs 4650.

Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow

Sensex Companies List 2022: Tata Motors to replace Dr Reddy's in S&P BSE Sensex from tomorrow

Fri, Dec 16, 2022

Sensex reshuffle: The rejig in the benchmark index is a part of the periodic reshuffle done in the index. The reshuffle happens twice a year -- June and December. It is based on a float-adjusted market cap weighted methodology.

Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

Dr Reddy's, Sun Pharma recall products in US for manufacturing issues

Mon, Dec 05, 2022

As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy's Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose.

Sensex reshuffle: Tata Motors to replace Dr Reddy’s, effective from December 19

Sensex reshuffle: Tata Motors to replace Dr Reddy’s, effective from December 19

Mon, Nov 21, 2022

Sensex reshuffle: Indian automotive manufacturer Tata Motors will replace pharmaceutical company Dr Reddy’s Laboratories in the 30-share benchmark S&P BSE Sensex effective Monday, December 19, 2022.

Dr Reddy's Laboratories share trade in green in early trade with over 1% surge after Q2 result: Check target given by brokerages

Dr Reddy's Laboratories share trade in green in early trade with over 1% surge after Q2 result: Check target given by brokerages

Mon, Oct 31, 2022

Dr Reddy share price: Dr Reddy's stock was trading in green on both the indices with more than 1 per cent surge.

Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma

Dr Reddy's Lab inks licensing pact with US-based Slayback Pharma

Sat, Jul 30, 2022

The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the Hyderabad-based firm said in a statement.

Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say

Dr Reddy’s Lab share price cracks nearly 5% amid lower-than-expected Q1 earnings – know what brokerages say

Fri, Jul 29, 2022

The pharma major reported poor performance on the margins front as well as weak US and Europe sales during the June-end quarter of the financial year 2022-23 (Q1FY23), brokerages believe.

Dr Reddy's shares surge 8% post q4 earnings; What should investors do?

Dr Reddy's shares surge 8% post q4 earnings; What should investors do?

Fri, May 20, 2022

Shares of Dr Reddy's surged eight per cent amid a spurt in volume to Rs 4247 a share on Friday's intraday trade after the company came out with its earnings for the quarter ended March 31, 2022

Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30

Dr Reddy's Q4 Results: PAT down 76% YoY on impacted by impairment charges; company announces dividend of Rs 30

Thu, May 19, 2022

Dr Reddy's Laboratories Limited reported a 76 per cent declne in its net profit at Rs 88 cr for the quarter ended 31 December. The Profit After Tax (PAT) reported by the company in the corresponding quarter in the year-ago period stood at Rs 362.4 cr

Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months

Technical Check: After forming a double bottom pattern Divi’s Laboratories eyes 20% upside in next 6-9 months

Fri, Mar 25, 2022

Divi’s Laboratories Ltd has risen nearly 30 per cent in the last one year compared to 20 per cent upside seen in the Nifty50 in the same period, and the technical charts suggest that momentum is likely to continue

Buy, Sell or Hold: What should investors do with Dr Reddy’s Laboratories, Hero MotoCorp and TCS?

Buy, Sell or Hold: What should investors do with Dr Reddy’s Laboratories, Hero MotoCorp and TCS?

Wed, Mar 23, 2022

Here's what Santosh Meena, Head of Research, Swastika Investmart Ltd, recommends investors should do with these stocks when the market resumes trading today.

8 Nifty50 stocks including HDFC twins, Dr Reddy’s, UltraTech, HUL hit 52-week lows; here is what brokerage opines

8 Nifty50 stocks including HDFC twins, Dr Reddy’s, UltraTech, HUL hit 52-week lows; here is what brokerage opines

Fri, Mar 04, 2022

Similarly, total 26 stocks from the Nifty500 index such as Ashok Leyland, Apollo Tyres, Ramco Cement, Dalmia Bharat, JK Cements, Kansai Nerolac and SBI Cards and Payment Services among others hit their respective 52-week lows

Buy, Sell or Hold: What should investors do with Maruti Suzuki, HDFC and Dr Reddy’s Laboratories?

Buy, Sell or Hold: What should investors do with Maruti Suzuki, HDFC and Dr Reddy’s Laboratories?

Thu, Mar 03, 2022

Stocks that were in focus include Maruti Suzuki that closed with losses of over 6 per cent, HDFC Ltd fell nearly 4 per cent and Dr Reddy’s Laboratories was down more than 5 per cent on Wednesday

Dr Reddy’s Q3FY22: Pharma major reports Rs 707 cr PAT, sales surge 8% YoY; margins dip

Dr Reddy’s Q3FY22: Pharma major reports Rs 707 cr PAT, sales surge 8% YoY; margins dip

Fri, Jan 28, 2022

Both top line and bottom line of the company registered positive year-on-year growth, while margins slipped marginally during the quarter.

Dr Reddy’s Q3FY22 Preview: Net profit, sales could see double-digit YoY growth for this pharma major

Dr Reddy’s Q3FY22 Preview: Net profit, sales could see double-digit YoY growth for this pharma major

Wed, Jan 26, 2022

Pharma major Dr Reddy’s Laboratories is likely to report a robust October-December quarter earnings for the financial year 2021-22 on Friday.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x